Comparative Effectiveness of Rivaroxaban, Apixaban, and Warfarin in Atrial Fibrillation Patients With Polypharmacy.

Stroke; a Journal of Cerebral Circulation
Amgad MentiasMary Vaughan Sarrazin

Abstract

Comparative effectiveness and safety of oral anticoagulants in patients with atrial fibrillation and high polypharmacy are unknown. We used Medicare administrative data to evaluate patients with new atrial fibrillation diagnosis from 2015 to 2017, who initiated an oral anticoagulant within 90 days of diagnosis. Patients taking ≤3, 4 to 8, or ≥9 other prescription medications were categorized as having low, moderate, or high polypharmacy, respectively. Within polypharmacy categories, patients receiving apixaban 5 mg twice daily, rivaroxaban 20 mg once daily, or warfarin were matched using a 3-way propensity score matching. Study outcomes included ischemic stroke, bleeding, and all-cause mortality. The study cohort included 6985 patients using apixaban, 3838 using rivaroxaban, and 6639 using warfarin. In the propensity-matched cohorts there was no difference in risk of ischemic stroke between the 3 drugs in patients with low and moderate polypharmacy. However, among patients with high polypharmacy, the risk of ischemic stroke was higher with apixaban compared with warfarin (adjusted hazard ratio 2.34 [95% CI, 1.01-5.42]; P=0.05) and similar to rivaroxaban (adjusted hazard ratio, 1.38 [95% CI, 0.67-2.84]; P=0.4). There was no diff...Continue Reading

References

May 22, 2008·Expert Opinion on Investigational Drugs·Jonathan P PicciniRobert M Califf
Oct 4, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Nirmala RaghavanDonglu Zhang
Aug 22, 2009·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Joachim Stangier, Andreas Clemens
Aug 13, 2011·The New England Journal of Medicine·Manesh R PatelUNKNOWN ROCKET AF Investigators
Aug 30, 2011·The New England Journal of Medicine·Christopher B GrangerUNKNOWN ARISTOTLE Committees and Investigators
Mar 28, 2013·Epidemiology·Jeremy A RassenSebastian Schneeweiss
Oct 1, 2013·Expert Opinion on Drug Safety·Robert L MaherEmily R Hajjar
May 17, 2014·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Benjamin A SteinbergUNKNOWN ROCKET AF Steering Committee and Investigators
Aug 20, 2014·Current Cardiology Reports·Manisha DesaiKen Mahaffey
Oct 11, 2014·Journal of the American College of Cardiology·Greg FlakerUNKNOWN ARISTOTLE Committees and Investigators
Mar 5, 2016·Circulation. Cardiovascular Quality and Outcomes·Geoffrey D BarnesJames B Froehlich
Mar 26, 2016·BMJ Open·Seyede Salehe MortazaviShervin Assari
Aug 23, 2017·The Annals of Thoracic Surgery·Waqaar KhawarSaqib Masroor
Mar 27, 2018·Current Cardiology Reports·Fahad ShaikhCaleb Ferguson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Related Papers

Canadian Medical Association Journal
Nursing Standard
Georgina Ingham
The American Journal of Psychiatry
M Ostow
JAMA : the Journal of the American Medical Association
Graziano Onder, Alessandra Marengoni
The Australian and New Zealand Journal of Psychiatry
R Khanna
© 2022 Meta ULC. All rights reserved